USANA Health Sciences, Inc.
USNA
$29.39
-$0.63-2.10%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 111.09% | -58.01% | 1.68% | -36.92% | -1.37% |
| Total Depreciation and Amortization | 74.12% | 5.85% | -2.51% | 12.16% | 4.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 462.66% | -80.14% | 234.82% | -146.87% | 64.10% |
| Change in Net Operating Assets | -72.68% | -164.01% | 286.70% | 59.95% | -5,172.02% |
| Cash from Operations | 167.62% | -80.41% | 269.64% | -54.82% | -32.05% |
| Capital Expenditure | -55.55% | 24.89% | 10.18% | 16.56% | 56.29% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -100.00% | 50.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 229.31% | -- |
| Cash from Investing | 98.11% | -8,674.08% | -51.23% | 62.00% | 44.44% |
| Total Debt Issued | -- | 1,150,000.00% | -101.30% | -71.32% | -32.20% |
| Total Debt Repaid | -- | 100.00% | 100.20% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -19,450.00% | 6.33% | -154.84% | 99.75% | -9,215.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -163.09% | 29,497.44% | 94.24% | 88.67% | -1,915.50% |
| Foreign Exchange rate Adjustments | 110.56% | -225.00% | 633.07% | 73.17% | -193.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.83% | -662.65% | 700.34% | 290.14% | -109.14% |